Category: Finance
-
Gene Therapy Company Acquired in $4.3B Deal
Spark Therapeutics, a biotechnology company that pioneered gene therapies, is being acquired by drug maker Roche Group in a deal valued at $4.3 billion.
-
Start-Up Raises $10.5M for Precision Immunotherapies
A new biotechnology enterprise developing personalized treatments that harness the immune system to treat cancer is raising $10.5 million in its first venture funding round.
-
Smart Watch in Development for Respiratory Diseases
A watch-like device is being designed to monitor for early onset of respiratory diseases like the flu, well before noticeable symptoms develop.
-
Company to Stop Cancer Spread, Relapse Raises $60.8M
A new company formed to commercialize research that aims to prevent cancer from spreading or recurring is raising $60.75 million in its first venture financing.
-
Venture Fund Formed to Back Longevity Research
A new venture capital fund is being formed to finance start-up companies developing technologies that aim to extend healthy human life spans.
-
Infographic – Apple Phone Sales Down, Wearables Up
Apple makes more than phones, and while the volume of sales in these other company units is smaller, the percentage gains from last year are healthy.
-
Foundation Backs Engineered T-Cells to Treat Lymphoma
A new initiative is researching modified immune system cells to treat T-cell lymphoma, a type of blood-related cancer, with a simpler, lower-cost process.
-
RNA Therapy Studied for Parkinson’s Side Effects
Medical researchers are developing a treatment for a frequent side-effect of Parkinson’s disease drugs using a corrective RNA molecule to reverse the condition.
-
Start-Ups Saying No Thanks to Venture Capital
Yesterday, we reported on 2018 being a banner year for venture capital, but the New York Times says a movement of entrepreneurs is looking for other ways to raise money.
-
Infographic – Venture Finance Reaching Dot-Com Levels
Venture funding last year totaled $99.5 billion, the largest annual outlay since 2000.